The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned

EuroIntervention 2016;12:1271-1278. DOI: 10.4244/EIJV12I10A208

1. Division of Cardiology, Iwate Medical University, Morioka, Iwate, Japan; 2. Department of Cardiology, Sakakibara Heart Institute, Tokyo, Japan; 3. Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan; 4. Depa

Aims: The aim of the study was to investigate the six-month angiographic and nine-month clinical follow-up outcomes in a first-in-man study using the biodegradable polymer-based cobalt-ch

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Clinical and multimodality imaging results at 6 months of a bioresorbable sirolimus-eluting scaffold for patients with single de novo coronary artery lesions: the NeoVas first-in-man trial